Literature DB >> 5031244

Leiomyosarcoma of the uterus.

W M Christopherson, E O Williamson, L A Gray.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 5031244     DOI： 10.1002/1097-0142(197206)29:6<1512::aid-cncr2820290615>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

Review 1.  Leiomyoma with nuclear atypia: Rare diseases that present a common diagnostic problem.

Authors:  Jian-Jun Wei
Journal:  Semin Diagn Pathol       Date:  2022-02-02       Impact factor: 3.893

2.  Primary leiomyosarcoma of the lesser sac--report of a case.

Authors:  K Souda; T Shiramizu; N Oka; H Tsurumaru; Y Miyamoto
Journal:  Jpn J Surg       Date:  1984-11

Review 3.  A case of multiple leiomyomatous lesions of the lung: an analysis of flow cytometry and hormone receptors.

Authors:  T Uchida; T Tokumaru; H Kojima; K Nakagawaji; M Imaizumi; T Abe
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

4.  Uterine leiomyosarcoma in pregnancy.

Authors:  J S Younis; E Okon; S O Anteby
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

5.  Uterine leiomyosarcoma with intracerebral metastasis: a case report.

Authors:  P R Prussia; H A Clarke; G Mansoor; S Garriques; B Maheswaran
Journal:  J Natl Med Assoc       Date:  1992-04       Impact factor: 1.798

Review 6.  Leiomyosarcoma in bone: primary or secondary? A case report and review of the literature.

Authors:  V L Fornasier; D Paley
Journal:  Skeletal Radiol       Date:  1983       Impact factor: 2.199

7.  Uterine sarcomas in Port Harcourt, Nigeria: a 12-year clinico-pathologic study.

Authors:  D Seleye-Fubara; S A Uzoigwe
Journal:  Afr Health Sci       Date:  2007-03       Impact factor: 0.927

8.  Analysis of uterine corporeal mesenchymal tumors occurring after menopause.

Authors:  Yumi Ishidera; Hiroshi Yoshida; Yuka Oi; Kayo Katayama; Etsuko Miyagi; Hiroyuki Hayashi; Hiroyuki Shigeta
Journal:  BMC Womens Health       Date:  2019-01-18       Impact factor: 2.809
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.